Investor Presentaiton

Favorable gross margin pathway enabled by Medicare ADLT pricing $500 ASP One-year post-FDA approval, enabled by favorable ADLT pricing for Medicare beneficiaries $200 COGS INVESTOR 20 DAY 23 When processing 1 million samples per year, enabled by Shield technology and high-throughput automation GUARDANT™ These numbers are approximate based on internal modeling 119

View entire presentation